The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed, most often at Series B.
Venture capitalbiovision.vcRounds from 2022-06-22 to 2026-01-08
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Diagonal Therapeutics They develop innovative clustering antibodies for the treatment of genetic diseases. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2026-01-08 | [ PART ] |
Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $27M |
| 2022-06-22 |
| [ PART ] |